Product
Meningococcal Group C-CRM197 Conjugate Vaccine
1 clinical trial
1 indication
Indication
Meningococcal immunizationClinical trial
Phase I Study of the Safety and Immunogenicity of a Quadrivalent Meningococcal (A, C, Y and W-135) Polysaccharide Tetanus Protein Conjugate Vaccine in Adults, Toddlers, and InfantsStatus: Completed, Estimated PCD: 2008-08-27